HIVe Home
ID#: PAR-11-108     Posted: 15 Mar 2011
Centers for AIDS Research and Developmental Centers for AIDS Research (P30) PAR-11-108
Deadline: 14 Jun 2013
Apply Here
Type of Grant: Research
Topics/Fields of Support: Adjuvants, Animal model studies, B cell immunology and antibody functions, Clinical trial site challenges, HIV transmission and acute HIV infection, Human genomics, Immune escape, Innate immunity, Mucosal immunity, Novel immunogens, inserts and vectors, Pediatric and adolescent infections and trials, Preclinical and clinical prophylactic vaccine trials, Preclinical and clinical therapeutic trials, Prevention strategies, Social, ethical, access and regulatory issues, T cell immunity, Vaccine concepts and design, Viral Diversity, Other

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency—making important medical discoveries that improve health and save lives.

Thanks in large part to NIH-funded medical research, Americans today are living longer and healthier. Life expectancy in the United States has jumped from 47 years in 1900 to 77 years today, and disability in people over age 65 has dropped dramatically in the past 3 decades. In recent years, nationwide rates of new diagnoses and deaths from all cancers combined have fallen significantly.

Scientific Leadership

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe.

NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's activities and outlook.

The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities.

More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 3,000 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research.

Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms  that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers.

Visit web site


1. Research Objectives

Participating Institutes of the National Institutes of Health (NIH) invite applications for Center Core grants (P30) to support Centers for AIDS Research as either standard CFARs (CFAR) or Developmental CFARs (D-CFAR).  CFAR and D-CFAR cores provide infrastructure and promote basic, clinical, behavioral and translational HIV/AIDS research activities at institutions that receive significant HIV/AIDS funding from NIH Institutes or Centers.  CFARs and D-CFARs can foster synergy and improve coordination of research, support emerging research opportunities, and promote efficiencies through resources shared by multiple independent laboratories.  CFARs and D-CFARs are intended to promote all HIV/AIDS research efforts at CFAR institutions.  D-CFARs provide support to assist investigators in the development of a competitive standard CFAR.  This Funding Opportunity Announcement (FOA) also defines a process for CFAR competitive supplements.  Before preparing an application to support a CFAR or D-CFAR, investigators are urged to consult with the Program staff listed in Section VII under "Agency Contacts: Scientific/Research Contacts."


This  FOA will use the NIH Center Core grant (P30) award mechanism.  The NIH P30 mechanism is for a Center Core grant that provides support for shared resources and facilities for a multidisciplinary research team or group of investigators focusing on a common research topic.  Funded independently of a center's component or program projects, the core grant provides accessible resources.

This FOA describes two types of CFAR awards.  The first is for a Developmental CFAR (D-CFAR) for HIV/AIDS investigators at an institution that is eligible, but does not yet have a CFAR.  The D-CFAR will provide the support necessary to develop a collaborative network that may permit the institution to be more competitive for a standard CFAR award.  The second type of award is for a standard CFAR (CFAR).  Both the D-CFAR and the CFAR are funded through the P30 mechanism for infrastructure development.  This FOA describes requirements for both types of CFARs. 

D-CFARs qualify for a base of $750,000 total cost in the first year as determined by the $6M minimum required funded research base (FRB) for the institution.

Standard CFARs qualify for three tiers of funding based on the FRB for the institution.

  • Tier 1: For institutions with a minimum of $6M, but less than $40M FRB, a CFAR award will use a base of $1.5M total cost in the first year of the competing segment.
  • Tier 2: For institutions with a minimum of $40M but less than $80M FRB, a CFAR award will use a base of $2.25M total cost in the first year of the competing segment.
  • Tier 3: For institutions with a minimum of $80M FRB, a CFAR award will use a base of $3M total cost in the first year of the competing segment.

Throughout this FOA, the terminology used for P30 applications for both CFARs and D-CFARs is "CFAR applications" and the corresponding terminology for P30 awards to support CFARs and D-CFARs is "CFAR awards."  "Core" or "core facilities" are defined as entities providing services or expertise to be shared by multiple independent laboratories.  All eligibility requirements and specific descriptions provided in this FOA for the CFAR applications also apply to D-CFAR applications.  The FOA does, however, provide some specific review criteria that only applies to D-CFAR applications.  Standard CFAR and D-CFAR applications have the same minimum number and types of Cores, namely: one Administrative, one Developmental, one Basic Science and one Clinical Science Core. 

The FOA also describes the concept of a Scientific Working Group.  A Scientific Working Group is defined as a specific area of scientific focus for a group of investigators who share common research interests and goals and participate in competitively funded research.  Although, CFAR and D-CFAR applications require a minimum of four Cores as described in the previous paragraph, Scientific Working Groups are optional for both CFAR and D-CFAR applications.


The CFAR program was established in 1988 and renewed in 1993, 1997, 2000, 2004, 2006, and 2009.  The mission of the CFAR program and mechanisms for achieving the mission were developed by CFAR Directors in 1995 and revised in 1996, 1998, and in the 2002 Position Statement of the NIH CFAR Directors.  (

The mission of CFAR is to support multi-disciplinary environments that promote basic, clinical, epidemiological, behavioral, and translational research in the prevention, detection, and treatment of HIV infection and AIDS. The CFAR program accomplishes this mission by:

  • Providing scientific leadership and institutional infrastructure dedicated to HIV/AIDS research
  • Stimulating scientific collaboration in interdisciplinary and translational research
  • Strengthening capacity for HIV/AIDS research in resource-limited settings
  • Fostering scientific communication
  • Sponsoring training and education
  • Promoting knowledge of CFAR research findings and the importance of HIV/AIDS research through community outreach
  • Promoting and supporting innovative NIH HIV/AIDS research initiatives
  • Establishing collaborative research between and among CFARs, and supporting HIV/AIDS research networks
  • Facilitating technology transfer and development through promotion of scientific interactions between CFARs and industry
  • Supporting research on prevention and treatment of HIV infection in hard-to-reach populations, especially inner city, rural poor, and disadvantaged minorities.

CFAR added value.  CFARs are expected to provide added value to the applicant institution's HIV/AIDS research efforts through support of activities that cannot easily be provided through standard research grant awards.  The added value contribution that the proposed CFAR will make at the institution(s) should go beyond what would be expected from the pre-existing AIDS funded research.  CFARs should promote and encourage activities that enhance collaboration and coordination of HIV/AIDS research.  An appropriate goal for CFARs is to promote translational research activities, i.e., basic scientists provide clinicians with new tools for use in patients and for assessment of their impact, and clinical researchers make novel observations about the nature and progression of disease that often stimulate basic investigations.

Some examples of how added value can be measured include:

  • Developmental Core awards resulting in collaborations, publications, or successful major research grants
  • Interdisciplinary publications
  • Evidence of CFAR enhancement and support of existing programs at the institution
  • Research activities initiated to address prevention and treatment questions in hard-to-reach populations (inner city, rural poor, and disadvantaged minorities)
  • Development and utilization of a program income mechanism (see PROGRAM INCOME SYSTEM in Section IV.6) for Cores
  • The initiation of institutional support for activities previously supported by the CFAR.
  • Mentoring and training of young investigators.
  • Promoting and supporting new collaboration and moving the HIV/AIDS field forward through CFAR-sponsored meetings and activities.

CFARs are expected to serve the research needs of NIH-funded HIV/AIDS investigators at the applicant institutions. The aims of the Cores and the services they provide should address the needs of HIV/AIDS investigators at the applicant institution(s) and be inclusive of the full range of HIV/AIDS science funded at that institution(s).  Applicants should describe in detail the operation of each proposed Core, i.e., its quality control, procedures, safety, training, etc., and how the proposed policies and procedures protect and incorporate the divergent needs of CFAR investigators (see additional details concerning policies and procedures under " Overall Research Strategy”). 

Applicants are encouraged to contact Program staff listed under "Agency Contacts" in Section VII. Agency Contacts to discuss planned strategies for fostering collaboration among HIV/AIDS investigators from divergent disciplines within the proposed CFAR.  Applicants for renewal CFARs should describe how other NIH-funded HIV/AIDS programs, if funded at the institution, will participate in the CFAR.  Specific programs funded by the co-funding institutes are listed under the "Overall Research Strategy” in Section IV.6.

CFAR awards support four different types of cores: Administrative, Developmental, Basic Science, and Clinical Science.  Each CFAR must have one Administrative and one Developmental Core, and a minimum of one Basic and one Clinical Science Core to optimally support the HIV/AIDS research at the applicant institution(s).  The definition of what constitutes a Basic or Clinical Core is sufficiently broad to meet the needs of the applicant institution(s), and may vary among CFAR applicants.  For example, epidemiology, biostatistics, ethnography, and behavioral cores could be classified as either Basic or Clinical Cores, depending on their focus.  Clinical Cores are likely to have more direct interaction with patients.

An applicant's initial choice of Basic and Clinical Cores is an important measure of the science management process.  Applicants should describe the Basic and Clinical Cores to be supported at the time that the CFAR is awarded, how the choice of cores was made, other potential cores that were evaluated but not selected, mechanisms for evaluating the utilization of proposed cores, criteria for increasing or decreasing funding of these cores, and process for adding or deleting cores during the course of the award.

CFARs have scientific and fiscal flexibility.  CFARs have the responsibility to use their resources to meet the needs of their investigators.  A CFAR has the authority to change allocation of resources according to the guidelines of CFAR operating policies and procedures.  A CFAR has considerable flexibility and authority in that they can alter funding of a Basic or Clinical Core, delete a core, or initiate a new core.  Applicants should state what policies and procedures will be used as the basis for reallocation of initial core funds to permit the establishment of new cores, as needed, without additional funding.  Applicants should describe how proposed policies and procedures provide structure for decision-making on several levels (e.g., CFAR Director, Core Director(s), internal advisory board, external advisory board, and CFAR investigators), and how each of the individuals or groups would participate in the decision process. Applicants should also state the process for informing the NIH of major changes in the CFAR.

The extent to which CFAR funding may leverage other resources in support of HIV/AIDS research is an important measure of a CFAR's value to HIV/AIDS investigators.  Basic and Clinical Cores may be supported totally, or in part, by CFAR funds.  Applicants are encouraged to develop creative collaborations to improve utilization of existing resources.  Convincing justification will be required for duplication of any Basic or Clinical Core that exists in a similar form elsewhere in the applicant institution(s).  Applicants should describe how cores with partial CFAR funding will be used to enhance the research of CFAR investigators.  For example, a CFAR core supported by other funding (e.g., of an NIAID AIDS Clinical Trial Unit or an NCI Cancer Center core facility) may become more accessible to HIV/AIDS investigators through leveraging of existing resources by the CFAR. 

Responsible management includes annual reporting of progress.  NIH has developed guidelines that specify the kind of information required in annual progress reports in order to answer questions from various constituencies, including Congress.  NIH staff will assess the previous progress reports from investigators submitting renewal applications, as well as responses to requests for additional information.  Results of this assessment will be made available to the applicant and if necessary, may be considered when making final funding decisions.  Assessments will reflect general trends during the funding period, rather than any single outstanding or insufficient response.

CFARs have the option to incorporate Scientific Working Groups.  A Scientific Working Group is defined as a specific area of scientific focus for a group of investigators who share common research interests and goals and participate in competitively funded research.  CFARs are encouraged, but not required, to identify one to three Scientific Working Groups in order to (1) take full advantage of the ability of CFARs to organize HIV/AIDS research at an institution, (2) encourage collaboration among scientific disciplines and diverse areas of expertise, and (3) explore significant questions and problems in HIV/AIDS that are not being addressed.  Each Scientific Working Group should capitalize on areas of excellence at that particular CFAR and should encourage interdisciplinary collaboration among investigators who have not previously collaborated with each other, or within that area of scientific focus.   A Scientific Working Group serves to unite a subgroup of CFAR scientists, whereas essential Cores are used by all or most CFAR members and provide services and expertise.  Applicants must address clearly the interaction between the Scientific Working Group(s) and the CFAR Cores. 

Additional CFAR-supported activities.  CFARs traditionally use a variety of strategies to achieve the objectives of the award.  Examples include industry collaborations, community outreach, development of scientists from diverse backgrounds underrepresented in in HIV/AIDS research, mentoring young investigators, HIV/AIDS research communications to non-scientists, CFAR-sponsored seminars and meetings, development of approaches to problems in enrollment and retention of women and minority groups in AIDS clinical trials, international collaborations, identifying additional support for ongoing NIH programs not planned in the initial award, CFAR-CFAR collaborations, and other activities that meet the HIV/AIDS research needs of applicant institutions.

Applicants are encouraged to explore collaborative, multi-institutional linkages with international and domestic sites, Historically Black Colleges and Universities (HBCUs) and international institutions.  Examples of linkages include mentoring, collaborating, and training.  Such linkages foster research training and collaborative studies and are able to meet needs that cannot be easily addressed by other funding mechanisms.  Coordination with international programs funded by the Fogarty International Center (FIC) is strongly encouraged.  CFARs also collaborate with each other in scientific areas of common interest to achieve economies of scale, to share unique resources and expertise, and to expand collaborative activities between CFARs, especially in areas that cannot be studied at a single CFAR site.  Examples of inter-CFAR collaborations can be found on the CFAR website (see  

Developmental CFARs (D-CFAR).  The purpose of the D-CFAR is to provide support for pre-CFAR applicants, to develop collaborations, experiment with core facilities that may be important to support HIV/AIDS investigators at the institution, and to correct any deficiencies that might adversely affect an application for a standard CFAR award.  The emphasis expected in a D-CFAR application will be the identification and clear description of gaps or deficiencies that would hinder development of a competitive CFAR application, and Core facilities that would reduce or eliminate these gaps.  For example, applicants may wish to initiate HIV/AIDS studies with investigators in resource-limited settings or expand collaborations between behavioral science and basic science investigators at an institution that has traditionally had a more narrow scientific focus in HIV/AIDS-related research.  Other examples include expansion of communications technology among investigators who have begun, or are planning collaborative studies, using the Developmental Core to fund a study that encompasses two scientific disciplines (especially two that may not have previously collaborated), or developing an outreach program that could not be initiated with institutional or research grant funding

Like the standard CFAR award, a D-CFAR provides funding to foster synergy and improve coordination of research, to support emerging research opportunities, and to promote economy of scale through resources shared by multiple independent laboratories.  D-CFARs also encourage other activities that serve the requirements of HIV/AIDS research (see below). Any of these activities may be fostered through a D-CFAR award.

Additional Budget Information

The size and maximum funding level of each award will depend on the type of CFAR award as described below.  The maximum funding level is determined by the NIH AIDS-funded research base (FRB), described in Section III, of an institution or group of institutions.  A CFAR cannot use the FRB of an institution that is already part of another CFAR.  The FRB of the previous fiscal year (defined as beginning October 1) to which an application is submitted will be used to determine eligibility. See web posting for additional budget information.

See grant posting webpage on NIH website for application details.


Applications due: June 14, 2011, June 14, 2012 and June 14, 2013 , by 5:00 PM local time of applicant organization.

Eligibility Information

1. Eligible Applicants
Eligible Organizations

Higher Education Institutions:

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For profit Organizations

  • Small Businesses
  • For-Profit Organizations (Other than Small Businesses)


  • State Governments
  • County Governments
  • City or Township Governments
  • Special District Governments
  • Indian/Native American Tribal Governments (Federally Recognized)
  • Indian/Native American Tribal Governments (Other than Federally Recognized)
  • U.S. Territory or Possession


  • Independent School Districts
  • Public Housing Authorities/Indian Housing Authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Faith-based or Community-based Organizations
  • Regional Organizations

Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are allowed.

Required Registrations

Applicant organizations must complete the following registrations as described in the PHS398 Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.

All Program Directors/Principal Investigators (PD/PIs) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.

All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least four (4) weeks prior to the application due date.

Eligible Individuals (Project Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

Only one PD/PI may be designated on the application.

2. Cost Sharing

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

3. Additional Information on Eligibility
Number of Applications

Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.

NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application. NIH will not accept any application that is essentially the same as one already reviewed. Resubmission applications may be submitted, according to the NIH Policy on Resubmission Applications from the PHS398 Application Guide.

CFAR- and D-CFAR-specific Eligibility Requirements:

1) NIH AIDS Funded Research Base (FRB)

To be eligible for a CFAR award an institution must have a significant NIH AIDS-funded research base (FRB).  The FRB is defined as the amount of Total Cost funding from NIH for one fiscal year (October 1 to September 30) preceding the calendar year of application submission.  For the D-CFAR and CFAR awards, an FRB in excess of $6M is required.  In addition, CFAR applicants must maintain the required minimum FRB during the year of submission in order to be funded at the requested amount.  For example, if an applicant has an FRB in 2010 that makes them eligible for $2.25M in funding, they must maintain the required FRB for funding at the $2.25M funding level in 2011 in order to be funded at that level.  This applies only to competing applications.

The research base includes peer-reviewed HIV/AIDS program projects, research grants, and cooperative agreements utilizing the following mechanisms only:  P01, R00, R01, R03, R18, R21, R21/R33, R24, R33, R34, R35, R37, U01, U10, U19, U24, U54, and K series awards.  Excluded from the NIH AIDS FRB are all funds from any source other than NIH.  A CFAR applicant cannot use the FRB of an institution that is already part of another CFAR.  Furthermore, for grants in the FRB that are more than $5M, the awarded institution can only take credit for the amount that is budgeted for their institution.  The rest of the funds will not count toward their FRB or the FRB of the subcontracted institution(s). The NIH AIDS FRB is compiled from the OAR database and can be requested by the applicant institution to determine eligibility. More information can be found in Section IV.6 under the heading “Spreadsheets, Tables, and Website.”

2) One CFAR award per institution

No institution will receive more than one CFAR award.  An institution participating in a multi-institutional CFAR application may not be included in any other CFAR application.  Independent campuses that are part of a large multiple city university are considered to be separate institutions, and each may submit one application.  Applicants are encouraged to contact program staff listed under "Agency Contacts" (Section VII) for additional guidance. 

3) Guidelines for multi-institutional CFARs 

In some cases two or more institutions that can demonstrate a credible plan for collaborative research networks using CFAR cores may wish to submit an application for a single CFAR award.  The request for multi-institutional applications should include the following indicators:

  • a demonstration of exceptional need to establish collaboration between multiple investigators at each of the applicant institutions
  • evidence of unique plans, such as the development of organized communications systems to overcome the scientific and management challenges that are naturally a part of multi-institutional collaborations
  • specific plans to address any anticipated budgetary challenges in the transfer of funds and resources from one institution to another
  • evidence for centralized authority of the CFAR Director for the purpose of management of the CFAR facilities at other sites

Multi-institutional CFAR applications may combine the NIH AIDS-funded research of all the investigators at the institutions participating in the proposed CFAR to meet the NIH AIDS-Funded Research Base requirement.  A multi-institutional CFAR application must designate a lead institution that will receive the award and provide details of agreements regarding coordination and support of cores and activities at other participating institutions.

CFARs that use a distant institution for a core facility may not use the Funded Research Base of any single investigator at that institution if they are not including all of the NIH AIDS investigators at that institution as part of the CFAR.

4) Cores outside of the CFAR institution

With appropriate justification, CFAR awards may support a core at an institution that is not part of the CFAR, including a foreign institution that provides a unique resource such as a clinical site or a primate facility.  NIH AIDS funding of the investigators at this core facility is not included as part of the FRB of the CFAR (see Funded Research Base).

5) D-CFAR application

Applicants who have never received a CFAR award are eligible to apply, as are previous CFAR applicants who have not been successful in competing for an award, and previous recipients who were not successful in renewing their CFAR award.  Applicants who have not received a CFAR award may choose to apply for either a standard CFAR or D-CFAR award.


Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Please check the following website for any changes in contact information:  

Application Submission Contacts

GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
Telephone 301-435-0714, TTY 301-451-5936

eRA Commons Help Desk(Questions regarding eRA Commons registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939

Scientific/Research Contact(s)

For questions regarding D-CFAR, or CFAR management issues, scientific issues, or program interests of NIAID please contact:

Ann Namkung Lee, M.P.H.
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room 4211, MSC-7626
6700-B Rockledge Drive
Bethesda, MD 20892-7626
Telephone: (301) 496-9176, FAX: (301) 402-3211

For questions regarding D-CFAR, or CFAR scientific issues or program interests of other NIH Institutes or Centers please contact:

Jeanne McDermott, Ph.D.
Division of International Training and Research
Fogarty International Center
Room B2C39, MSC-2220
31 Center Drive
Bethesda, MD  20892-2220
Telephone: (301)-496-1492, FAX: (301) 402-0779

Geraldina Dominguez, Ph.D.
Office of HIV and AIDS Malignancy
National Cancer Institute
Room 3135, MSC-2440
31 Center Drive
Bethesda, MD  20892-2440
Telephone: (301) 496-3204, FAX:  (301) 480-4137

Cheryl L. McDonald, M.D.
Division of Cardiovascular Diseases
National Heart, Lung, and Blood Institute
Rockledge II, Room 8114, MSC-7940
6701 Rockledge Drive
Bethesda, MD 20892-7940
Telephone: (301) 435-0560, Email:

Basil A. Eldadah, M.D., Ph.D.
Division of Geriatrics and Clinical Gerontology
National Institute on Aging
7201 Wisconsin Avenue
Gateway Building, Suite 3C-307, MSC-9205
Bethesda, MD 20892-9205
Telephone: (301) 496-6761, Fax: (301) 402-1784

Jag Khalsa, Ph.D.
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse
Room 4137, MSC-9551
6001 Executive Boulevard
Bethesda, MD 20892-9551
Telephone: (301) 443-2159, FAX: (301) 594-2599

Christopher, Gordon, Ph.D.
Division of Mental Disorders, Behavioral Research & AIDS
National Institute of Mental Health
Room 6204, MSC-9621
6001 Executive Boulevard
Bethesda, MD  20892-9621
Telephone: (301) 443-1613, FAX: (301) 443-9719

Susan F. Newcomer Ph.D.
Demographic and Behavioral Sciences Branch (DBS)
Eunice Kennedy Shriver Kennedy National Institute of Child Health and Human Development (NICHD)
6100 Executive Boulevard, Room 8B07G, MSC 7510
Bethesda, MD 20892-7510
(Rockville, Maryland 20852 for non USPS/courier service)
Telephone: 301-435 6981, Email:

Peer Review Contact(s)

Peter R. Jackson, Ph.D.
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 3133, MSC-7616
6700B Rockledge Drive
Bethesda, MD 20892-7616
Bethesda, MD 20817-7616 (for express/courier service; non-USPS mail)
Telephone: (301) 496-8426 
FAX: (301) 480-2408

Financial/Grants Management Contact(s)

Deanna L. Ingersoll
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 2110, MSC-7614
6700-B Rockledge Drive
Bethesda, MD 20892-7614
Telephone:  (301) 451-2686, FAX: (301) 493-0597